EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years

Emily Rayens iD, Jennifer H Ku, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Julia E Tubert, Gina S Lee iD, Punam P Modha, Yoonyoung Park, Tianyu Sun iD, Evan J Anderson und 1 weitere

Influenza and Other Respiratory Viruses · 2024

DOI: 10.1111/irv.70025 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Emily Rayens und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Hospitalization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moderna, Inc, Moderna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective cohort study evaluated the comparative vaccine effectiveness (cVE) of licensed standard‐dose cell‐based versus egg‐based influenza vaccines in preventing influenza hospitalization among adults 18–64 years during the 2022–2023 season. The cohort included eligible Kaiser Permanente Southern California members who received ≥ 1 dose of influenza vaccine ( n = 848,334). The adjusted cVE against influenza hospitalization was −10.1% (95% CI: −49.8%, 37.8%) in the 18‐ to 49‐year‐old cohort. In the 50‐ to 64‐year‐old cohort, the adjusted cVE was 14.9% (−33.8%, 52.1%). Cell‐based and egg‐based influenza vaccines conferred comparable protection against influenza hospitalization in adults 18–64 years of age in the 2022–2023 season.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanHospitalizationHumansAdultMiddle AgedRetrospective StudiesAdolescentFemaleYoung AdultMaleVaccine EfficacySeasonsVaccinationCalifornia

Stichwörter der Autor:innen

Influenzaepidemiologyinfluenza vaccinevaccine effectiveness

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Division of Clinical Development, Moderna Inc, Cambridge, Massachusetts, USA.
  • Division of Real-World Evidence Analytics, Moderna Inc, Cambridge, Massachusetts, USA.
  • Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.

ORCID-Profile: Emily Rayens, Gina S Lee, Tianyu Sun

Förderung

  • Moderna, Inc
  • Moderna

Zitieren

APA

Rayens, E., Ku, J. H., Sy, L. S., Qian, L., Ackerson, B. K., Luo, Y., Tubert, J. E., Lee, G. S., Modha, P. P., Park, Y., Sun, T., Anderson, E. J., & Tseng, H. F. (2024). Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70025

Vancouver

Rayens E, Ku JH, Sy LS, Qian L, Ackerson BK, Luo Y, et al. Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.70025

BibTeX
@article{Rayens2024,
  author = {Rayens, Emily and Ku, Jennifer H and Sy, Lina S and Qian, Lei and Ackerson, Bradley K and Luo, Yi and Tubert, Julia E and Lee, Gina S and Modha, Punam P and Park, Yoonyoung and Sun, Tianyu and Anderson, Evan J and Tseng, Hung Fu},
  title = {Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  doi = {10.1111/irv.70025}
}
Kostenlos starten →